Credit Suisse Downgrades Gilead Sciences To Neutral

Loading...
Loading...
Analysts at Credit Suisse downgraded
Gilead Sciences Inc. GILD
from Outperform to Neutral. The price target for Gilead Sciences has been lowered from $130 to $115. Gilead Sciences shares have surged 26.86% over the past 52 weeks, while the S&P 500 index has gained 14.77% in the same period. Gilead Sciences' shares fell 1.15% to $98.75 in pre-market trading.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsCredit Suisse
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...